title: [Utility of methoxy isobutyl isonitrile (MIBI) scintigraphy, ultrasound and computerized axial tomography in preoperative topographic diagnosis of hiperparathyroidism].
abstract: OBJECTIVE
  1. To assess the sensitivity of scintigraphy using methoxy isobutyl isonitrile (MIBI). 2. To compare its resolution with that of ultrasound (US) and computerized axial tomography (CAT). 3. To use its diagnostic reliability to determine whether selective approaches can be used to treat hyperparathyroidism (HPT).
  
  
  METHODS
  A study of 76 patients who underwent surgery for HPT between 1996 and 2005 was performed. MIBI scintigraphy and cervical US were used for whole-body scanning in all patients; CAT was used in 47 patients. Intraoperative and postoperative biopsies were used for final evaluation of the tests, after visualization and surgical extirpation.
  
  
  RESULTS
  The results of scintigraphy were positive in 65 patients (85.52%). The diagnosis was correct in all of the single images. Multiple images were due to hyperplasia and parathyroid adenomas with thyroid disease (5.2%). Three images, incorrectly classified as negative (3.94%), were positive. The sensitivity of US was 63% and allowed detection of three MIBI-negative adenomas (4%). CAT was less sensitive (55%), but detected a further three MIBI-negative adenomas (4%).
  
  
  CONCLUSIONS
  1. The sensitivity of MIBI reached 89.46%. In the absence of thyroid nodules, MIBI diagnosed 100% of single lesions. Pathological thyroid processes produced false-positive results (5.2%) and there were diagnostic errors (4%). 2. MIBI scintigraphy was more sensitive than US and CAT. 3. Positive, single image scintigraphy allows a selective cervical approach. US and CAT may help to save a further 8% of patients (with negative scintigraphy).
authors.affiliation: Servicio de Cirugía General. Cátedra de Cirugía. Universidad del País Vasco. Hospital de Basurto. Bilbao. España. agpalaci@hbas.osakidetza.net
authors.forename: Angel
authors.initials: A
authors.lastname: Gómez Palacios
authors.forename: Jesús
authors.initials: J
authors.lastname: Gómez Zábala
authors.forename: María Teresa
authors.initials: MT
authors.lastname: Gutiérrez
authors.forename: Amaya
authors.initials: A
authors.lastname: Expósito
authors.forename: Borja
authors.initials: B
authors.lastname: Barrios
authors.forename: Angel
authors.initials: A
authors.lastname: Zorraquino
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Taibo
authors.forename: Ignacio
authors.initials: I
authors.lastname: Iturburu
mesh_terms: D000236:Adenoma / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000601:surgery; D006965:Hyperplasia / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009333:Neck / Q000000981:diagnostic imaging; D010279:Parathyroid Diseases; D010280:Parathyroid Glands / Q000473:pathology; D010282:Parathyroid Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography; D051598:Whole Body Imaging
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi